
DM506 is a novel ibogamine derivative and ингибитор of α7 and α9α10 nicotinic acetylcholine receptors (nAChRs) с IC50 of 5.1 uM, 5.6 uM and 6.4 uM for α9α10, α7β2 and α7nAChR, respectively.
DM506 is a novel ibogamine derivative and inhibitor of α7 and α9α10 nicotinic acetylcholine receptors (nAChRs) with IC50 of 5.1 uM, 5.6 uM and 6.4 uM for α9α10, α7β2 and α7nAChR, respectively.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.